BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 21258649)

  • 1. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
    Martin LJ
    Pharmaceuticals (Basel); 2010; 3(4):839-915. PubMed ID: 21258649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of mitochondria in neurodegenerative diseases.
    Martin LJ
    Prog Mol Biol Transl Sci; 2012; 107():355-415. PubMed ID: 22482456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial pathobiology in ALS.
    Martin LJ
    J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
    Martin LJ
    Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
    Martin LJ
    Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, mitochondrial damage and neurodegenerative diseases.
    Guo C; Sun L; Chen X; Zhang D
    Neural Regen Res; 2013 Jul; 8(21):2003-14. PubMed ID: 25206509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Insight into the Molecular Mechanism of Mitochondrial Toxicant-induced Neuronal Apoptosis in Parkinson's Disease.
    Brahadeeswaran S; Lateef M; Calivarathan L
    Curr Mol Med; 2023; 23(1):63-75. PubMed ID: 35125081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative diseases and oxidative stress.
    Emerit J; Edeas M; Bricaire F
    Biomed Pharmacother; 2004 Jan; 58(1):39-46. PubMed ID: 14739060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
    Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
    Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.